arrow
S

Samantha Pozzi

Università di Modena e Reggio Emilia
H指数:34
被引数:4,266

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Increased risk of secondary malignancies after autologous transplantation in R/R follicular lymphoma: Long-term results from FIL-FLAZ12 Phase III trial

自体移植后复发/难治性滤泡性淋巴瘤患者继发恶性肿瘤风险增加:FIL-FLAZ12 III期试验的长期结果

2026-08-120
OAAI
Obinutuzumab does not improve complete methabolic response but does not compromise mobilization or engraftment of autologous peripheral blood stem cells in diffuse large B cell lymphoma: Results from a fondazione italiana linfomi prospective phase II study (the GIOTTO study)
2022-06-050
PRE
Nonpeghylated liposomal doxorubicin combination regimen (R-COMP) for the treatment of lymphoma patients with advanced age or cardiac comorbidity
2020-07-0917
OAAI
Neutrophil-lymphocyte ratio at diagnosis is an independent prognostic factor in patients with nodular sclerosis Hodgkin lymphoma: results of a large multicenter study involving 990 patients

诊断时的中性粒细胞-淋巴细胞比率是结节性硬化症霍奇金淋巴瘤患者的独立预后因素: 一项涉及990例患者的大型多中心研究的结果

2016-10-2835
OAAI
Safety and efficacy of lenalidomide in combination with rituximab in recurrent indolent non-follicular lymphoma: final results of a phase II study conducted by the Fondazione Italiana Linfomi

来那度胺与利妥昔单抗联合治疗复发性惰性非滤泡性淋巴瘤的安全性和有效性: 由意大利Fondazione Linfomi进行的II期研究的最终结果

2016-02-0816
OAAI
Antimyeloma Activity of a Multitargeted Kinase Inhibitor, AT9283, via Potent Aurora Kinase and STAT3 Inhibition Either Alone or in Combination with Lenalidomide
2011-05-1558
OAAI
Dual Inhibition of Akt/Mammalian Target of Rapamycin Pathway by Nanoparticle Albumin-Bound-Rapamycin and Perifosine Induces Antitumor Activity in Multiple Myeloma

纳米颗粒白蛋白结合雷帕霉素和Perifosine双重抑制Akt/雷帕霉素途径的哺乳动物靶标在多发性骨髓瘤中的抗肿瘤活性

2010-04-07162
OAAI
Activin A promotes multiple myeloma-induced osteolysis and is a promising target for myeloma bone disease
2010-03-01214
OAAI